LEVOMEPROMAZINE

SynDRA canonical compound SYN0020323 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	DRD4
Mechanism of action	Dopamine receptor antagonist
Indication	bipolar disorder \| insomnia \| nausea \| psychosis \| schizophrenia
Disease area	gastroenterology \| neurology/psychiatry

All known targets

DRD2
DRD4
DRD3
HRH1
ADRA1A
ADRA1B
HTR2C
HTR2A
DRD5
DRD1
CHRM5
CHRM4

Mechanisms of action (all sources)

Dopamine receptor antagonist
DRD2 ANTAGONIST
D2-like dopamine receptor antagonist
DRD3 ANTAGONIST
DRD4 ANTAGONIST
DRD2 MODULATOR

Drug classes

Analgesics
Analgesics, Non-Narcotic
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Neurotransmitter Agents
Peripheral Nervous System Agents
Psychotropic Drugs
Sensory System Agents
Tranquilizing Agents

ATC classes

N05A · ANTIPSYCHOTICS

Cross-references

PubChem CID: 72287
ChEMBL: CHEMBL1764
DrugBank: DB01403
ChEBI: CHEBI:6838
KEGG: D00403
Wikipedia: Levomepromazine
TTD: D09LZT
LINCS BRD: BRD-K35559145

Synonyms

Look up LEVOMEPROMAZINE in the interactive SynDRA portal →